{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:59:38Z","timestamp":1780678778816,"version":"3.54.1"},"reference-count":62,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1517\/13543784.6.2.173","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T16:44:06Z","timestamp":1115225046000},"page":"173-189","source":"Crossref","is-referenced-by-count":13,"title":["Valaciclovir:development, clinical utility and potential"],"prefix":"10.1517","volume":"6","author":[{"given":"Raj","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209103271108"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_B.9"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91725-4"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680260052005"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92248-1"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198503000-00014"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.150.9.1881"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00002"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.4.942"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/14.6.661"},{"key":"CIT0015","first-page":"79","volume":"85","author":"WOOD MJ","year":"1988","journal-title":"Am. J. Med."},{"key":"CIT0016","first-page":"84","volume":"85","author":"HUFF JC","year":"1988","journal-title":"BALFOUR HFI etal.: Therapy of herpes zoster with acyclovir. Am. J. Med."},{"key":"CIT0017","first-page":"93","volume":"102","author":"MORTON P","year":"1989","journal-title":"N. Z Med. J."},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.341"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.Supplement_3.S495"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070010077031"},{"key":"CIT0021","first-page":"518\u2013S24","volume":"5","author":"KATLAMA C","year":"1992","journal-title":"CAUMES E eta].: Foscarnet induc-tion therapy for cytomegalovirus ntinitis in AIDS: comparison of twice-daily and three-times daily regi-mens. J. Acquir. Immune Defic. Syndr."},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.2.444"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905253202105"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91835-X"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.5.2.169"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1177\/095632029300400201"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/095632029300401S01","volume":"4","author":"BOYD MR","year":"1993","journal-title":"Antiviral Chem. Chemother."},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1128\/AAC.40.5.1282","volume":"40","author":"KO RBA BE","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1177\/09563202930040S602"},{"key":"CIT0035","volume":"25","author":"EDITORIAL","year":"1993","journal-title":"Mar-ket Letter (October"},{"key":"CIT0036","first-page":"595","volume":"54","author":"WELLER S","year":"1993","journal-title":"DOUCETTE M eta].:Pharmacoki- netics of the acyclovir prodrug valaciclovir after esca- la ting single- and multiple-dose administration to nor-mal volunteers. Clin. Pharmacol Ther."},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1177\/095632029200300305"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1993.018.07.218439"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.355"},{"key":"CIT0040","first-page":"97","volume":"3","author":"NUSINOFF-LEHRMAN S","year":"1993","journal-title":"Antiviral Chemother."},{"key":"CIT0041","first-page":"60","volume":"22","author":"BURNETTE TC","year":"1994","journal-title":"Drug. Metab. aspos."},{"key":"CIT0042","first-page":"55\u2013","volume":"22","author":"DE MIRANDA P","year":"1994","journal-title":"Drug. Metab. Dispos."},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.12.2759"},{"key":"CIT0047","first-page":"89","volume":"6","author":"ERTL P","year":"1995","journal-title":"LOWE D eta].: A comparative study of the in vitro a nd in vivo antiviral activities of acyclovir and penciclovir. Antimicrob. Agents Chemother."},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1016\/S0021-9258(18)83248-3","volume":"264","author":"REARDON JE","year":"1989","journal-title":"J Biol. Chem."},{"key":"CIT0049","first-page":"518","volume":"20","author":"FURMAN PA","year":"1981","journal-title":"CLAIR MH et al.: Metabo-lism of acyclovir in virus infected and uninfected cells. Antimicrob. Agents Chemother."},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/0924-8579(94)90011-6"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(84)90023-8"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1038\/289081a0"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.26.15827"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529050-00003"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198308030-00001"},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/AAC.40.1.80","volume":"40","author":"WANG LH","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0066","first-page":"1534","volume":"38","author":"JACOBSON MA","year":"1994","journal-title":"WANG LH eta].: Phase I trialof valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease. Antimicrob. Agents Chemother."},{"key":"CIT0067","first-page":"383","volume":"37","author":"DE BONY F","year":"1996","journal-title":"PECK R eta].: Lack of interactionbetween valaciclovir, the L-valyl ester of aciclovir, and Maalox antacid. J. Antimicrob. Chemother."},{"key":"CIT0072","first-page":"1089","volume":"36","author":"WOOD MJ","year":"1995","journal-title":"BEUTNER K eta].: How should zoster trials be conducted? J. Antimicrob. Chem other."},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.7.1546"},{"key":"CIT0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/003591576505800101","volume":"58","author":"HOPE-SIMPSON RE","year":"1965","journal-title":"Proc. Roy. Soc. Med."},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.02980030041010"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440140169018"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.4.831"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-4-585"},{"key":"CIT0095","first-page":"1223","volume":"166","author":"GALLANT JE","year":"1992","journal-title":"The Zidovudine Epidemiology Study Group. J. Infect. Dis."},{"key":"CIT0096","first-page":"1250","volume":"101","author":"STUDIES OF OCULAR COMPLICATIONS OF AIDS RE-SEARCH GROUP IN COLLABORATION WITH THE AIDS CLINICAL TRIALS GROUP","year":"1994","journal-title":"Oph-thalmology"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801143180202"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199302000-00007"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199405000-00010"},{"key":"CIT0102","first-page":"879","volume":"23","author":"CHULAY JD","year":"1996","journal-title":"Clin. Infect Dis."},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.206"},{"key":"CIT0104","first-page":"172","volume":"72","author":"KELLEHER P","year":"1996","journal-title":"Genitourin. Med."},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1177\/09563202950060S609"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.6.2.173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T15:00:19Z","timestamp":1625929219000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.6.2.173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,2,23]]},"published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1517\/13543784.6.2.173"],"URL":"https:\/\/doi.org\/10.1517\/13543784.6.2.173","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}